XORTX Therapeutics Inc. Impairment Loss Recognised In Other Comprehensive Income
XORTX Therapeutics Inc. (XRTX) reported Impairment Loss Recognised In Other Comprehensive Income of CAD 116.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncome · last filed 2022-05-03
| Period end | Impairment Loss Recognised In Other Comprehensive Income 12 month |
|---|---|
| 2021-12-31 | 116.00K CAD 20-F · filed 2022-05-03 |